Day-to-day fasting self-monitored blood glucose variability is associated with risk of hypoglycaemia in insulin-treated patients with type 1 and type 2 diabetes: A post hoc analysis of the SWITCH Trials.

For severe hypoglycaemia, a similar pattern of an increased number of hypoglycaemic episodes per 100 PYE, with higher day‐to‐day fasting SMBG variability,was observed; however, it did not reach statistical significance in patients with T2D ( P = 0.1140) (Table 2 and Figure S3 , Supporting Information).

also in 111,027 other papers